Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.

Diagnostic pathology - 18 Apr 2023

Seo Gabriella T, Minkowitz Jeremy, Kapustin Danielle A, Fan Jun, Minkowitz Gerald, Minkowitz Miriam, Dowling Eric, Matloob Ammar, Asti Divya, Dhar Meekoo, Shutty Christopher, Brickman Alan, Urken Mark L, Brandwein-Weber Margaret, Finkelstein Sydney D

Abstract excerpt

BACKGROUND: Struma ovarii is an unusual ovarian teratoma containing predominantly thyroid tissue. Less than 10% of cases undergo malignant transformation in the thyroid tissue and are considered malignant struma ovarii (MSO). MSO have been reported with concurrent thyroid lesions, but molecular data is lacking. CASE PRESENTATION: A 42-year-old female developed MSO and synchronous multifocal subcentimeter...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Iodine Radioisotopes
Share to Loss of Heterozygosity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MicroRNAs

Share to Mutation

Share to Ovarian Neoplasms

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37072862
DOI: 10.1186/s13000-023-01336-6
PMCID: PMC10111709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.PMID 37072862Read ↗

RET/PTC rearrangement in papillary thyroid carcinoma arising in malignant struma ovarii with abdominal wall metastasis and cervical thyroid gland: A case report and review of the literatureSemantic proximity Read ↗

Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.Semantic proximity Read ↗

Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.Semantic proximity Read ↗

Malignant struma ovarii: Advances in molecular pathogenesis, classification, diagnosis and treatment.Semantic proximity Read ↗

Malignant struma ovarii: clinicopathological and molecular features in a series of nine cases.Semantic proximity Read ↗

BRAF in papillary thyroid carcinoma of ovary (struma ovarii).Semantic proximity Read ↗

RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.Semantic proximity Read ↗

Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.Semantic proximity Read ↗

Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.Semantic proximity Read ↗

The molecular profile of ovarian struma ovarii.Semantic proximity Read ↗

Malignant Clinical Course of Histologically Benign Ovarian Struma: case report and literature reviewSemantic proximity Read ↗

A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.